---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-013050"
form_type: "8-K"
ticker: "CGC"
cik: "0001737927"
company_name: "Canopy Growth Corp"
filed_at: "2024-02-09T23:59:59+00:00"
generated_at: "2026-06-06T04:55:23.518089+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Canopy Growth Q3 FY2024 revenue $78.5M; adjusted EBITDA loss narrows 82% to $9M

## Summary
- Net revenue $78.5M, down 7% YoY; net loss from continuing operations $230.3M.
- Adjusted EBITDA loss $9.0M, improving 82% from $50M loss in Q3 FY2023.
- Canada medical cannabis revenue record $15.6M (+11% YoY); Canada B2B adult-use revenue up 9%.
- Cash and short-term investments $186M; debt reduced by $69M during quarter.
- Canopy USA special meeting set for April 12, 2024; board appoints two new directors.

## SEC filing metadata
- accession: 0000950170-24-013050
- form_type: 8-K
- ticker: CGC
- cik: 0001737927
- company_name: Canopy Growth Corp
- filed_at: 2024-02-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737927/000095017024013050/0000950170-24-013050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737927/000095017024013050/cgc-20240209.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-013050
- JSON: https://secwatch.observer/filing/0000950170-24-013050.json
- Plain text: https://secwatch.observer/filing/0000950170-24-013050.txt

## Key facts
- Earnings Releases
  Canopy Growth Corp reported fiscal third quarter ended December 31, 2023 results: revenue $79MM, net income $(230.3). Guidance reaffirmed.
  - Period: fiscal third quarter ended December 31, 2023
  - Revenue: $79MM
  - Net income: $(230.3)
  - Guidance: reaffirmed
  - Result: reported results
  source text: divestiture of the Canada national retail business in Q3 FY2023, Q3 FY2024 consolidated net revenue grew by 6% year-over-year. Delivered Q3 FY2024 consolidated net revenue of $79MM representing a decline of 7% year-over-year. • Rest-of-World cannabis revenue in Q3 FY2024 increased 81% year-over-year, led by continued strong growth in Australia, return to
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737927/000095017024013050/0000950170-24-013050-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.